July 20, 2021
New Study of a Novel Metabolic Procedure with Self-Assembling Magnets for Obese Patients with Type 2 Diabetes deemed safe and feasible.
September 30, 2020
U.S. FDA Grants GI Windows Medical Corp, Breakthrough Device Designation for Magnetic Anastomosis Technology
January 26, 2021
GI Windows featured in JJDC 2020 Annual Newsletter highlighting it's investment in GI Windows
August 19, 2020
GI Windows Corp, a clinical-stage, privately-held medical device company, announced a $16.4 million Series A-1. The financing attracted Johnson & Johnson Innovation - JJDC, along with Sonder Capital, GT Healthcare, JC Investco and one additional strategic investo
December 8, 2020
GI Windows Named Winner of Emerging MedTech Company of the Year
December 12, 2019
GI Windows Corp, a clinical-stage, privately-held medical device company, announced a $14.6 million Series A financing